Efficacy of Aflibercept for the treatment of diabetic macular oedema in patients refractory to Ranibizumab

被引：0
|
作者：
Clarke, Holly [1 ]
Sepetis, Anastasios [1 ]
Rennie, Christina [1 ]
Lotery, Andrew [1 ]
Sahu, Debendra [1 ]
Inzerillo, Dario [1 ]
Gupta, Bhaskar [1 ]
机构：
[1] Univ Hosp Southampton, Southampton, Hants, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3606
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Treatment outcomes of intravitreal ranibizumab for diabetic macular oedema in vitrectomised eyes
    Lu, Vicky Hsin-Ju
    Antao, Sheelah
    Fajgenbaum, Mark
    Wong, Roger
    Bainbridge, James W. B.
    da Cruz, Lyndon
    Hamilton, Robin D.
    Rajendram, Ranjan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [42] Real-world outcomes of Ranibizumab treatment for Diabetic Macular Oedema
    Patrao, Namritha Valerie
    Antao, Sheelah
    Sim, Dawn A.
    Sivaprasad, Sobha
    Andrews, Richard
    Hamilton, Robin
    Egan, Catherine A.
    Tufail, Adnan
    Hykin, Philip G.
    Rajendram, Ranjan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [43] PROGNOSTIC FACTORS IN THE TREATMENT OF DIABETIC MACULAR OEDEMA (DMO) USING AFLIBERCEPT, RANIBIZUMAB AND BEVACIZUMAB (DRCR.NET PROTOCOL T)
    Gerendas, B. S.
    Bogunoivic, H. B.
    Schlegl, T.
    Sadeghipour, A.
    Waldstein, S. M.
    Schmidt-Erfurth, U.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (04) : E89 - E89
  • [44] Factors affecting central macular thickness of diabetic macular oedema patients after an induction treatment of intravitreal ranibizumab
    Nursyafiqah, Md Tahir
    Siti-Azrin, Ab Hamid
    Yaacob, Najib Majdi
    Wan-Nor-Asyikeen, Wan-Adnan
    Zunaina, Embong
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2023, 28 (04) : 300 - 307
  • [45] Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
    Yun Wong
    David H. W. Steel
    Maged S. Habib
    Alex Stubbing-Moore
    Dalvir Bajwa
    Peter J. Avery
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 733 - 742
  • [46] Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
    Wong, Yun
    Steel, David H. W.
    Habib, Maged S.
    Stubbing-Moore, Alex
    Bajwa, Dalvir
    Avery, Peter J.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (04) : 733 - 742
  • [47] IMPACT OF INTRAVITREAL RANIBIZUMAB ON VESSEL FUNCTIONALITY IN PATIENTS WITH DIABETIC MACULAR OEDEMA
    Benatti, L.
    Tomasso, L.
    Corvi, F.
    Darvizeh, F.
    Querques, L.
    Querques, G.
    Bandello, F.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (04) : E104 - E104
  • [48] Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
    Razavi, Sam
    Kodjikian, Laurent
    Giocanti-Auregan, Audrey
    Dufour, Ingrid
    Souied, Eric
    BMC OPHTHALMOLOGY, 2021, 21 (01)
  • [49] Treatment of Diabetic Macular Edema with Aflibercept in Eyes with Previous Nonresponse to Ranibizumab and/or Bevacizumab
    Sadowsky, Rachel
    Quiram, Polly
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [50] Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
    Sam Razavi
    Laurent Kodjikian
    Audrey Giocanti-Aurégan
    Ingrid Dufour
    Eric Souied
    BMC Ophthalmology, 21
12345